White label ELPA - ClinicalTrials.eu

Study of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer stage II
- Non-small cell lung cancer stage III
Investigated drugs:
Study of JK06 for Patients with Advanced or Metastatic Cancer

Recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Jk06
Study of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)

Recruiting

2 1 1
Investigated diseases:
- Juvenile idiopathic arthritis
Investigated drugs:
- Sarilumab
+5
Study of GNT0003 and imlifidase in adults with Crigler-Najjar syndrome who require daily phototherapy and have pre-existing AAV8 antibodies

Recruiting

2 1 1 1
Investigated diseases:
- Crigler-Najjar syndrome
Investigated drugs:
Study on Encorafenib and Cetuximab for Patients with BRAF V600E-Mutated Localized Colon or Upper Rectum Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Rectal cancer
- Colon cancer
Investigated drugs:
- Encorafenib
- Cetuximab
Study on the Long-Term Safety of GTX-102 for Patients with Angelman Syndrome

Recruiting

3 1 1
Investigated diseases:
- Angelman’s syndrome
Investigated drugs:
Study on Blood Flow in the Vaginal Area After Total Laparoscopic Hysterectomy Using Indocyanine Green for Patients Undergoing Hysterectomy

Recruiting

3 1 1 1
Investigated diseases:
- Hysterectomy
Investigated drugs:
- Indocyanine Green
Study on HPV Vaccine Timing for Patients After Stem Cell Transplantation Using Gardasil 9

Recruiting

2 1 1 1
Investigated diseases:
- Allogenic stem cell transplantation
Investigated drugs:
Long-term Safety Study of AUTO4 and Rituximab in Patients with Potential Malignancy Treated with Autologous CAR T Cell Therapy

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

Recruiting

2 1 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
- Art6043
- Olaparib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies